Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 9, 1981The Journal of Clinical Pharmacology

Δ9‐Tetrahydrocannabinol As An Antiemetic For Patients Receiving Cancer Chemotherapy. A Pilot Study

View Full Paper
Ask AI
Bookmark
Share

Authors

DSDonald L. SweetNorthwestern UniversityNMNancy J. MillerColorado State UniversityWWWilliam W. WeddingtonUniversity of Chicago

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Sweet et al. (1981) studied this question.

synapsesocial.com/papers/6a127cfeea48cb855a34f2a7https://doi.org/10.1002/j.1552-4604.1981.tb02577.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Δ9-Tetrahydrocannabinol for Refractory Vomiting Induced by Cancer Chemotherapy1980 · 64 citations
  2. 2Delta-9-Tetrahydrocannabinol as an Antiemetic for Patients Receiving Cancer Chemotherapy1979 · 202 citations
  3. 3Antiemetic Effect of Delta-9-Tetrahydrocannabinol in Patients Receiving Cancer Chemotherapy1975 · 365 citations
  4. 4Antiemetics in Patients Receiving Chemotherapy for Cancer1980 · 261 citations